Emergence of a bacterial clone with enhanced virulence by acquisition of a phage encoding a secreted phospholipase A2

The molecular basis of pathogen clone emergence is relatively poorly understood. Acquisition of a bacteriophage encoding a previously unknown secreted phospholipase A2 (designated SlaA) has been implicated in the rapid emergence in the mid-1980s of a new hypervirulent clone of serotype M3 group A Streptococcus. Although several lines of circumstantial evidence suggest that SlaA is a virulence factor, this issue has not been addressed experimentally. We found that an isogenic ΔslaA mutant strain was significantly impaired in ability to adhere to and kill human epithelial cells compared with the wild-type parental strain. The mutant strain was less virulent for mice than the wild-type strain, and immunization with purified SlaA significantly protected mice from invasive disease. Importantly, the mutant strain was significantly attenuated for colonization in a monkey model of pharyngitis. We conclude that transductional acquisition of the ability of a GAS strain to produce SlaA enhanced the spread and virulence of the serotype M3 precursor strain. Hence, these studies identified a crucial molecular event underlying the evolution, rapid emergence, and widespread dissemination of unusually severe human infections caused by a distinct bacterial clone.

[1]  Meng-Yao Liu,et al.  Genome sequence of a serotype M3 strain of group A Streptococcus: Phage-encoded toxins, the high-virulence phenotype, and clone emergence , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Todd M. Smith,et al.  Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. Frank,et al.  ExoU is a potent intracellular phospholipase , 2004, Molecular microbiology.

[4]  Michal J. Nagiec,et al.  Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. Hauser,et al.  Pseudomonas aeruginosa ExoU, a Toxin Transported by the Type III Secretion System, Kills Saccharomyces cerevisiae , 2003, Infection and Immunity.

[6]  B. Beall,et al.  Array of M protein gene subtypes in 1064 recent invasive group A streptococcus isolates recovered from the active bacterial core surveillance. , 2003, The Journal of infectious diseases.

[7]  M. Cunningham,et al.  Pathogenesis of group A streptococcal infections. , 2000, Clinical microbiology reviews.

[8]  J. Vuopio‐Varkila,et al.  Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland. , 1997, The Journal of infectious diseases.

[9]  B. Schwartz,et al.  Severe group a streptococcal soft-tissue infections in Ontario: 1992-1996. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  N. Ruiz,et al.  Cytolysin-Mediated Translocation (CMT) A Functional Equivalent of Type III Secretion in Gram-Positive Bacteria , 2001, Cell.

[11]  M. Wessels,et al.  NAD+‐glycohydrolase acts as an intracellular toxin to enhance the extracellular survival of group A streptococci , 2002, Molecular microbiology.

[12]  Michal J. Nagiec,et al.  Analysis of a Novel Prophage-encoded Group A Streptococcus Extracellular Phospholipase A2* , 2004, Journal of Biological Chemistry.

[13]  A. Fauci,et al.  The challenge of emerging and re-emerging infectious diseases , 2004, Nature.

[14]  J. Musser,et al.  Distribution of streptococcal inhibitor of complement variants in pharyngitis and invasive isolates in an epidemic of serotype M1 group A Streptococcus infection. , 2001, The Journal of infectious diseases.

[15]  E. Dennis,et al.  In Vivo Phospholipase Activity of the Pseudomonas aeruginosa Cytotoxin ExoU and Protection of Mammalian Cells with Phospholipase A2 Inhibitors* , 2003, Journal of Biological Chemistry.

[16]  Adeline R. Whitney,et al.  Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Michal J. Nagiec,et al.  Genome sequence of a serotype M28 strain of group a streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity. , 2005, The Journal of infectious diseases.

[18]  J. Musser,et al.  Progress toward characterization of the group A Streptococcus metagenome: complete genome sequence of a macrolide-resistant serotype M6 strain. , 2004, The Journal of infectious diseases.

[19]  S. Hamada,et al.  Cytochrome c‐mediated caspase‐9 activation triggers apoptosis in Streptococcus pyogenes‐infected epithelial cells , 2001, Cellular microbiology.

[20]  J. Musser,et al.  Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events. , 2005, The Journal of infectious diseases.

[21]  Joshua Lederberg,et al.  Emerging Infections: Microbial Threats to Health in the United States , 1992 .

[22]  D E Low,et al.  Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. , 1996, The New England journal of medicine.

[23]  James M. Musser,et al.  Prophage Induction and Expression of Prophage-EncodedVirulence Factors in Group A Streptococcus Serotype M3 StrainMGAS315 , 2003, Infection and Immunity.

[24]  J. Musser,et al.  Growth Characteristics of and Virulence Factor Production by Group A Streptococcus during Cultivation in Human Saliva , 2005, Infection and Immunity.

[25]  M. Lei,et al.  The mechanism of action of the Pseudomonas aeruginosa‐encoded type III cytotoxin, ExoU , 2003, The EMBO journal.

[26]  J. Musser,et al.  Longitudinal analysis of the group A Streptococcus transcriptome in experimental pharyngitis in cynomolgus macaques. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Musser,et al.  Toward a genome-wide systems biology analysis of host-pathogen interactions in group A Streptococcus. , 2005, The American journal of pathology.

[28]  K. O'Brien,et al.  Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  J. Musser,et al.  Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. , 1997, The Journal of clinical investigation.

[30]  Adeline R. Whitney,et al.  Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Bruce A. Roe,et al.  Complete genome sequence of an M1 strain of Streptococcus pyogenes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  P. Tsai,et al.  Group A Streptococcus Induces Apoptosis in Human Epithelial Cells , 1999, Infection and Immunity.

[33]  Masahira Hattori,et al.  Genome sequence of an M3 strain of Streptococcus pyogenes reveals a large-scale genomic rearrangement in invasive strains and new insights into phage evolution. , 2003, Genome research.